|
SEC24D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.220600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.857500E-02 |
| Normal-vs-Stage2 |
1.743510E-02 |
| Normal-vs-Stage3 |
1.257990E-03 |
| Normal-vs-Stage4 |
3.883800E-03 |
| Stage1-vs-Stage2 |
3.862600E-01 |
| Stage1-vs-Stage3 |
1.491200E-01 |
| Stage1-vs-Stage4 |
2.276000E-01 |
| Stage2-vs-Stage3 |
8.783400E-01 |
| Stage2-vs-Stage4 |
8.204400E-01 |
| Stage3-vs-Stage4 |
8.988000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.656000E-03 |
| Normal-vs-AfricanAmerican |
4.712800E-01 |
| Normal-vs-Asian |
1.974370E-02 |
| Caucasian-vs-AfricanAmerican |
2.093200E-01 |
| Caucasian-vs-Asian |
9.827600E-01 |
| AfricanAmerican-vs-Asian |
3.028800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.164140E-03 |
| Normal-vs-Female |
1.668040E-02 |
| Male-vs-Female |
2.011800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.291700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.755000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.523070E-03 |
| Normal-vs-Age(81-100Yrs) |
5.205600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.727800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.381900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.509600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.021600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.634200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.395800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.590000E-01 |
| Classical-VS-Follicular |
1.940420E-01 |
| Classical-VS-Other |
1.342410E-01 |
| Classical-VS-Normal |
2.606200E-02 |
| Tall-VS-Follicular |
9.401600E-01 |
| Tall-VS-Other |
2.942400E-01 |
| Tall-VS-Normal |
1.439630E-02 |
| Follicular-VS-Other |
4.279800E-01 |
| Follicular-VS-Normal |
5.202400E-03 |
| Other-VS-Normal |
1.749830E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.284900E-03 |
| Normal-vs-N1 |
3.823500E-03 |
| N0-vs-N1 |
7.603800E-01 |
|
|
